COVID-19 Vaccine Created Using Tobacco Plants to Move Forward With Human Testing

COVID-19 Vaccine Created
Using Tobacco Plants to Move
Forward With Human Testing.
British American Tobacco (BAT) has won
approval in the United States to begin testing
its COVID-19 vaccine on adult volunteers. .
Enrollment for human trials is expected to start
shortly, with results hopefully by mid-2021. .
BAT is a multinational
tobacco company responsible
for brands such as Dunhill,
Lucky Strike and Pall Mall.
Its vaccine is reportedly unique
because it utilizes tobacco plants for
reproduction of its potential antigen. .
BAT claims that its vaccine can be produced in
just six weeks by turning tobacco plants
into “bio-manufacturing factories.”.
That is much faster than traditional
methods, which generally take months to
produce the same results.
It is our unique plant-based vaccine technology,
which acts as a fast, efficient host for the
production of antigens for a variety of diseases,
that has enabled us to make this progress, BAT’s Director of Scientific Research
Dr. David O’Reilly, via ‘The Guardian’.
In addition, BAT says its vaccine is
stable at room temperature, unlike the Pfizer
vaccine which must be kept at minus 70 degrees Celsius